Cargando…
Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
Autores principales: | de Roquetaillade, Charles, Guillemin, Jérémie, Beaucoté, Victor, Barthelemy, Romain, Chousterman, Benjamin Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722639/ https://www.ncbi.nlm.nih.gov/pubmed/34991792 http://dx.doi.org/10.1016/j.jacc.2021.09.1384 |
Ejemplares similares
-
Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients
por: de Roquetaillade, Charles, et al.
Publicado: (2022) -
Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery
por: Barthélémy, Romain, et al.
Publicado: (2021) -
Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU
por: Blet, Alice, et al.
Publicado: (2020) -
Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery
por: Ludes, Pierre-Olivier, et al.
Publicado: (2021) -
Systemic Inflammation Evaluated by Interleukin-6 or C-Reactive Protein in Critically Ill Patients: Results From the FROG-ICU Study
por: Picod, Adrien, et al.
Publicado: (2022)